Mexico’s New Regulatory Strategy Will Support Production And Development Of Biosimilars
Pharmaceuticals / Mexico / Wed 21 Feb, 2024
Key View
- Mexico’s proposed regulatory strategy will increase the availability and affordability of biosimilar medicines in the country.
- The enhancement of Mexico's regulatory policies for biosimilars will boost the country's domestic biopharmaceutical manufacturing sector.
- Mexico’s government focus on refining the regulatory framework